Lionhunter Capital Management’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.26M Buy
+110,000
New +$2.35M 1.01% 34

Other funds holding VRDN

Lionhunter Capital Management's VRDN Position: Q3 2026 in Review

Lionhunter Capital Management opened a new position in Viridian Therapeutics (VRDN) in Q3 2026: 110,000 shares worth $2.26M. The stake represents 1.01% of the portfolio and ranks #34 among its holdings.

154 funds tracked by Wall St. Rank hold VRDN as of Q3 2026.

  • Lionhunter Capital Management held 110,000 shares of Viridian Therapeutics worth $2.26M as of Q3 2026.
  • Viridian Therapeutics was a new Lionhunter Capital Management position in Q3 2026.
  • Viridian Therapeutics made up 1.01% of Lionhunter Capital Management's portfolio in Q3 2026, its #34 holding.
  • 154 funds tracked by Wall St. Rank held Viridian Therapeutics as of Q3 2026.

Based on Lionhunter Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.